Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review

Authors:

Abstract
Aim: This study summarized the existing evidence on the outcomes and safety of anti-PD-1s, anti-PD-L1s and anti-CTLA-4s in pediatric patients with melanoma.
Funding Information
  • Bristol Myers Squibb

This publication has 38 references indexed in Scilit: